Skip to main content
We are aware of current issues with the ONS login. Please clear your device history/cache/cookies before attempting to log in. Thank you for your patience as we address this issue.
cancel
Category

Recent FDA Approvals Continue to Focus on Targeted and Immunotherapy

  • Cancer Treatments;
  • Targeted Therapies;
  • Immunotherapy;
  • Clinical Trials;
  • Learn Cancer Care
Category

FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism

  • Symptoms and Side Effects;
  • Oncologic Emergencies;
  • Cancer Treatments;
  • Drug Names;
  • Learn Cancer Care;
  • Get Clinical Support and Guidance
Category

Critical Care for Patients With Cancer

  • Care Setting;
  • Coordination of Care;
  • Oncologic Emergencies;
  • Inpatient Care;
  • Care Transitions and Patient Handoffs;
  • Improve Quality and Safety;
  • Get Clinical Support and Guidance
Category

How Can Oncology and ICU Nurses Work Together to Treat Critically Ill Patients With Cancer?

  • Coordination of Care;
  • Care Setting;
  • Oncologic Emergencies;
  • Care Transitions and Patient Handoffs;
  • Inpatient Care;
  • Improve Quality and Safety;
  • Get Clinical Support and Guidance
Category

Oncology Treatments and Trends Continue to Change Rapidly

  • Cancer Treatments;
  • Advocacy and Policy;
  • Clinical Research;
  • Learn Cancer Care;
  • Get Clinical Support and Guidance
Category

FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease

  • Cancer Treatments;
  • Complementary/Alternative/Integrative Therapies;
  • Drug Names;
  • Learn Cancer Care;
  • Get Clinical Support and Guidance
Category

FDA Grants Regular Approval to Blinatumomab and Expands Indication to Include Philadelphia Chromosome-Positive B Cell ALL

  • Cancer Treatments;
  • Cancer Types;
  • Targeted Therapies;
  • Hematologic Malignancies;
  • Drug Names;
  • Leukemia;
  • Learn Cancer Care;
  • Get Clinical Support and Guidance
Category

ONS Answers Your Top Questions About Cancer Immunotherapy

  • Cancer Treatments;
  • Immunotherapy;
  • Get Clinical Support and Guidance
Category

FDA Approves Neratinib for Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

  • Cancer Treatments;
  • Cancer Types;
  • Targeted Therapies;
  • Breast Cancer;
  • Drug Names;
  • Learn Cancer Care;
  • Use Evidence Based Practice (EBP)
Category

The Case of the Immunotherapy Inquiry, Part II

  • Cancer Treatments;
  • Symptoms and Side Effects;
  • Immunotherapy;
  • Get Clinical Support and Guidance;
  • Use Evidence Based Practice (EBP)
Subscribe to
Back to Top ▲
Go to ons.org